Annals of Oncology

Published by: Oxford University Press  

People

  1. Solit
    Solit
  2. Chandarlapaty
    Chandarlapaty
  3. Ladanyi
    Ladanyi
  4. Berger
    Berger
  5. Chi
    Chi
  6. Schultz
    Schultz
  7. Riely
    Riely
  8. Selenica
    Selenica
  9. Weigelt
    Weigelt
  10. Gazzo
    Gazzo

Groups

  1. Human Oncology and Pathogenesis Program (84)
  2. GSK Faculty (83)
  3. Department of Medicine (66)
  4. Solid Tumor Oncology Division (65)
  5. Tow Center for Developmental Oncology (TCDO) (35)
  6. Breast Medicine Service (26)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (24)
  8. Sloan Kettering Institute Postdocs (24)
  9. Genitourinary Oncology Service (18)
  10. Epidemiology and Biostatistics (16)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (47)
  2. Journal Article (27)
  3. Guidelines (5)
  4. Review (3)
  5. Editorial (2)
Groups
  1. Human Oncology and Pathogenesis Program (84)
  2. GSK Faculty (83)
  3. Department of Medicine (66)
  4. Solid Tumor Oncology Division (65)
  5. Tow Center for Developmental Oncology (TCDO) (35)
  6. Breast Medicine Service (26)

More Groups

People
  1. Jorge Reis-Filho (26)
  2. Marc Ladanyi (19)
  3. Sarat Chandarlapaty (17)
  4. David Solit (16)
  5. Michael Berger (15)
  6. Britta Weigelt (11)

More People

Years
  1. 2023 (16)
  2. 2022 (8)
  3. 2021 (9)
  4. 2020 (10)
  5. 2019 (11)
  6. 2018 (4)

More Years

Publishers
  1. Oxford University Press (84)

Results (84)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Novel therapeutic opportunities in metaplastic breast cancer
    Meeting Abstract

    Pareja, F.; Gazzo, A.; Dopeso, H.; Brown, D.; Selenica, P.; Zhu, Y.; Blanco Heredia, J.; Gusain, L.; Pei, X.; Marra, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • CDC7 inhibition constrains lineage plasticity and prevents resistance and neuroendocrine transformation in the lung and prostate
    Meeting Abstract

    Quintanal-Villalonga, Á.; Zaidi, S.; Karthaus, W. R.; Zhan, Y. A.; Shafer, M.; Qiu, J.; de Stanchina, E.; Haffner, M. C.; Sawyers, C. L.; Rudin, C. M.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Alternative molecular mechanisms underpinning breast invasive lobular carcinoma identified by genomics-driven artificial intelligence model
    Meeting Abstract

    Pareja, F.; Dopeso, H.; Wang, Y. K.; Gazzo, A.; Brown, D.; Selenica, P.; Bernhard, J.; Sue, J.; Lee, M. C. H.; Godrich, R.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • APOBEC mutagenesis and macrophage infiltration in cancer
    Meeting Abstract

    Gazzo, A.; Marra, A.; Zhu, Y.; Gupta, A.; Selenica, P.; Pei, X.; Weigelt, B.; Pareja, F.; Riaz, N.; Reis, J. S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Pan-cancer prevalence of MET fusions and clinical response to MET- targeted therapy
    Meeting Abstract

    Vojnic, M.; Odintsov, I.; Liu, Z.; Lu, D.; Harshan, M.; Ameri, A.; Machnicki, S.; Xiao, X.; Lockwood, W.; Ladanyi, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Pan-cancer assessment of the impact of intronic variants on cancer development and progression
    Meeting Abstract

    Safonov, A.; Mehine, M.; Ceyhan-Birsoy, O.; Brown, D.; Bandlamudi, C.; Forbes, A.; Gazzo, A.; Selenica, P.; Shen, R.; Khurana, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • A first-in-human phase I trial of NB003, a potent and selective KIT/PDGFRa inhibitor, in patients with advanced gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Chi, P.; Shen, L.; Li, J.; Zhang, J.; Hu, K.; Zhang, L.; Xu, Y.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Detection of alternative lengthening of telomeres (ALT) across cancer types based on tumor-normal multigene panel sequencing
    Meeting Abstract

    Heredia, J. B.; Diplas, B. H.; El Nahhas, O. S. M.; Selenica, P.; Pareja, F.; Mandelker, D.; Weigelt, B.; Riaz, N.; Rosen, E.; Sfeir, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Combined patient specific tumor and HPV sequencing enables high sensitivity detection of ctDNA in HPV-associated oropharyngeal carcinoma patients
    Meeting Abstract

    Diplas, B. H.; Brown, D.; Pei, X.; Graybill, C.; Novaj, A.; Korn, W. M.; Daber, R.; Humm, J.; Shukla-Dave, A.; Schoder, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • INDIGO: A randomized, double-blinded, phase III study of vorasidenib versus placebo in IDH1 or IDH2 low-grade glioma
    Meeting Abstract

    Blumenthal, D.; Mellinghoff, I. K.; van den Bent, M. J.; Touat, M.; Peters, K.; Clarke, J.; Mendez, J.; Welsh, L.; Mason, W.; Hottinger, A. F.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save

    • Annals of Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Annals of Oncology 15698041 Oxford University Press On Behalf of the European Society for Medical Oncology
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 0923-7534 Unknown
    Annals of Oncology 09237534 Oxford University Press
    Annals of Oncology 15698041 Oxford University Press
    Annals of Oncology 09237534 The Author 2008
    Annals of Oncology 09237534 The Author 2013
    Annals of Oncology 09237534 The Author(s) 2018
    Annals of Oncology 09237534 The Author(s) 2019
    Annals of Oncology 0923-7534 Kluwer Academic Publishers
    Annals of Oncology 09237534 The Author 2007
    Annals of Oncology 09237534 Unknown
    Annals of Oncology 09237534 The Author
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 09237534 The Author(s)
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 09237534 The Author 2016
    Annals of Oncology 09237534 The Author 2017
    Annals of Oncology 09237534 The Author 2011
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 09237534 2023
    Annals of Oncology 09237534 The Author 2012
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 09237534 The Author 2015
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 0923-7534 Elsevier Inc.
    Annals of Oncology 0923-7534 European Society for Medical Oncology
    Annals of Oncology 09237534 Kluwer Academic Publishers
    Annals of Oncology 0923-7534 Oxford University Press
    Annals of Oncology 09237534 The Authors
    Annals of Oncology 09237534 Oxford University Press On Behalf of the European Society for Medical Oncology
    Annals of Oncology 0923-7534 Oxford University Press On Behalf of the European Society for Medical Oncology
    Annals of Oncology 09237534 European Society for Medical Oncology
    Annals of oncology : official journal of the European Society for Medical Oncology 15698041 Oxford University Press On Behalf of the European Society for Medical Oncology
    Annals of oncology : official journal of the European Society for Medical Oncology 15698041 Unknown
    Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 15698041 Unknown